BNP Paribas Bonus Zert MRK 30.12..../ DE000PN8G3V1 /
29/05/2024 14:20:20 | Chg.+0.220 | Bid14:44:12 | Ask14:44:12 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
202.390EUR | +0.11% | 202.320 Bid Size: 2,000 |
202.370 Ask Size: 2,000 |
MERCK KGAA O.N. | - EUR | 30/12/2024 | Call |
GlobeNewswire
13:02
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
13:00
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA